I Carroll - JoVE Visualize

Showing results (61-70 of 202) with videos related to

Pageof 21

Sort By:

Bioorganic & Medicinal Chemistry Letters|November 15, 2000

3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporterB E Blough, C R Holmquist, P Abraham, et al.

Neuropharmacology|April 1, 1996

Ibogaine block of the NMDA receptor: in vitro and in vivo studiesK Chen, T G Kokate, S D Donevan, et al.

Brain Research|December 2, 1996

Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sitesK Y Little, J Gorebig, F I Carroll, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2015

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTicJeffrey J Buda, F I Carroll, Thomas R Kosten, et al.

Synapse (New York, N.Y.)|August 15, 1998

Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortexJ W Boja, F I Carroll, R A Vaughan, et al.

Pharmaceutical Research|November 1, 1992

Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.

Journal of Medicinal Chemistry|August 1, 1987

Endoperoxides as potential antimalarial agentsJ A Kepler, A Philip, Y W Lee, et al.

Synapse (New York, N.Y.)|August 15, 1998

RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporterS I Dworkin, P Lambert, G M Sizemore, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001

Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activationP A Zaki, D E Keith, J B Thomas, et al.

European Journal of Pharmacology|September 12, 1996

Highly potent cocaine analogs cause long-lasting increases in locomotor activityA E Fleckenstein, T A Kopajtic, J W Boja, et al.

Pageof 21

Showing results (61-70 of 202) with videos related to

Sort By:

Pageof 21

Bioorganic & Medicinal Chemistry Letters|November 15, 2000

3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporterB E Blough, C R Holmquist, P Abraham, et al.

Neuropharmacology|April 1, 1996

Ibogaine block of the NMDA receptor: in vitro and in vivo studiesK Chen, T G Kokate, S D Donevan, et al.

Brain Research|December 2, 1996

Lack of dopamine receptor agonists effect on striatal dopamine transporter binding sitesK Y Little, J Gorebig, F I Carroll, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2015

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTicJeffrey J Buda, F I Carroll, Thomas R Kosten, et al.

Synapse (New York, N.Y.)|August 15, 1998

Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortexJ W Boja, F I Carroll, R A Vaughan, et al.

Pharmaceutical Research|November 1, 1992

Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.

Journal of Medicinal Chemistry|August 1, 1987

Endoperoxides as potential antimalarial agentsJ A Kepler, A Philip, Y W Lee, et al.

Synapse (New York, N.Y.)|August 15, 1998

RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporterS I Dworkin, P Lambert, G M Sizemore, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 16, 2001

Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activationP A Zaki, D E Keith, J B Thomas, et al.

European Journal of Pharmacology|September 12, 1996

Highly potent cocaine analogs cause long-lasting increases in locomotor activityA E Fleckenstein, T A Kopajtic, J W Boja, et al.

Pageof 21